Navigation Links
Antibody library project could unlock mysteries of human gene function

LOS ALAMOS, New Mexico, October 31, 2011 A National Institutes of Health (NIH) grant to Los Alamos National Laboratory Bioscience Division could help unravel the gnarly secrets of how many human genes function.

Originally discovered in the Human Genome Project, the approximately 20,000 genes of the human body have been slow to reveal their exact roles. And one of the best tools for exposing a gene's function is to take the protein it produces and generate specific antibodies, usually by vaccinating mice or rabbits. Antibodies are specialized proteins the immune system deploys to block the actions of potentially harmful bacteria and viruses.

By looking at antibodies, researchers can identify where, in a cell, genes are active and under what conditions they increase or decrease their expression. Antibodies are also one of the fastest growing classes of new therapeutics,with sales of about $40 billion in 2010.

With the new NIH Common Fund grant of more than $4 million, researchers led by Andrew Bradbury aim to develop an automated pipeline to generate antibodies against human gene products, without using animals.

Instead Dr. Bradbury's team will use "antibody libraries" expressed in bacteria and bakers yeast. These libraries are enormous, comprising billions of different antibodies, and the ultimate goal is to identify antibodies in the libraries that recognize each human protein. The broad availability of antibodies against all human proteins will facilitate the understanding of human disease and provide likely targets for therapeutic intervention, with the antibodies themselves potentially becoming therapeutic leads.

This project will leverage much of the technology that has been developed over the years at LANL, including flow cytometry, antibody libraries and fluorescentprotein technology, and has the potential to create a set of tools applicable to many different problems of interest to sponsors beyond NIH, including the U.S. Department of Energy and Department of Defense.


Contact: Nancy Ambrosiano
DOE/Los Alamos National Laboratory

Related biology news :

1. Xencor Initiates Phase 1 Study of XmAb®5871 Therapeutic Antibody for the Treatment of Autoimmune Diseases
2. B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome
3. Scientists report major advance in human antibody therapy against deadly Hendra virus
4. Powerful antibody-based strategy suggests a new therapeutic approach to diabetes and obesity
5. Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses
6. Discovery of natural antibody brings a universal flu vaccine a step closer
7. Epitomics Signs Agreement With Bayer for Antibody Technology
8. Researchers discover trigger to early, effective antibody response
9. Plastic antibody works in first tests in living animals
10. USU scientists report major advance in human antibody therapy against deadly Nipah virus
11. First human gets new antibody aimed at rabies virus
Post Your Comments:
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
(Date:11/12/2015)... --  Growing need for low-cost, easy to use, ... the way for use of biochemical sensors for ... clinical, agricultural, environmental, food and defense applications. Presently, ... applications, however, their adoption is increasing in agricultural, ... on improving product quality and growing need to ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
(Date:11/24/2015)... ALBANY, New York , November 24, 2015 /PRNewswire/ ... According to a recent market research report released by ... is projected to expand at a CAGR of 17.5% ... titled "Non-invasive Prenatal Testing Market - Global Industry Analysis, ... 2022", estimates the global non-invasive prenatal testing market to ...
Breaking Biology Technology: